(Q37115390)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18356814%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

review article

1 reference

title

Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18356814%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

Christopher H. Contag

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18356814%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

S H Thorne

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18356814%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

20 March 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18356814%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18356814%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18356814%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

753-758

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18356814%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18356814%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/gt.2008.42

4 January 2020

exact match

0 references

cites work

Ablating CAR and integrin binding in adenovirus vectors reduces nontarget organ transduction and permits sustained bloodstream persistence following intraperitoneal administration

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Ligand-directed targeting of genes to the site of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Targeted gene delivery by tropism-modified adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Antibody-targeted cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

In vivo cancer targeting and imaging with semiconductor quantum dots

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Tumor regression by targeted gene delivery to the neovasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Strategies to achieve systemic delivery of therapeutic cells and microbes to tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Combining immune cell and viral therapy for the treatment of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Oncolytic virotherapy: approaches to tumor targeting and enhancing antitumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Recent progress in the battle between oncolytic viruses and tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Rational strain selection and engineering creates a broad-spectrum, systemically effective oncolytic poxvirus, JX-963

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Looking and listening to light: the evolution of whole-body photonic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Synergistic antitumor effects of immune cell-viral biotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

It's not just about anatomy: in vivo bioluminescence imaging as an eyepiece into biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Molecular imaging of cancer with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Multi-modality imaging identifies key times for annexin V imaging as an early predictor of therapeutic outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

An improved bioluminescence resonance energy transfer strategy for imaging intracellular events in single cells and living subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Advances in in vivo bioluminescence imaging of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Tumor cell recognition by natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Applying the principles of stem-cell biology to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Dual promoter-controlled oncolytic adenovirus CG5757 has strong tumor selectivity and significant antitumor efficacy in preclinical models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Stem Cells and Cancer: Two Faces of Eve

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

Rescue and propagation of fully retargeted oncolytic measles viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

7 January 2021

Using in Vivo Bioluminescence Imaging to Shed Light on Cancer Biology

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

7 January 2021

Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

7 January 2021

Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

7 January 2021

Stem cells: the real culprits in cancer?

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.42

7 January 2021